The Senators (Ret.) Firm, LLP Haga clic aquí para visitar nuestro sitio web en Español
800.773.0849
Home About the Firm Meet The Attorneys Areas of Practice Verdicts and Settlements Contact Us
Read our recent case results Learn why you should hire our firm. Learn more about your legal rights.
Friend us on Facebook Follow us on Twitter View our Google+ Page
Accolades and Associations

Tradjenta® & Increased Risks for Pancreatic Cancer

Pursuing a Claim with a California Defective Drug Lawyer

Tradjenta (linagliptin) is a type-2 medication manufactured by Boehringer Ingelheim. While the drug was only approved by the U.S. Food and Drug Administration (FDA) in 2011, reports of adverse health risks have already begun to accumulate. As such, our California defective drug attorneys at The Senators Firm offer our support and experienced representation to patients who have suffered injuries and damages as the result of taking this new diabetes medication. Our legal team has spent years advocating on behalf of victims injured by corporate misconduct and unsafe medications, and we encourage all victims and families to learn more about their eligibility to pursue a claim and monetary compensation by bringing their case to the attention of our firm.

Tradjenta & Adverse Effects

Tradjenta is an oral type-2 diabetes medication that works by regulating blood glucose levels. Although relatively new on the market, the FDA has already initiated investigations into the possible risks posed by the drug. Just as with other diabetes medications of the incretin mimetics class, Tradjenta has been linked to the following:

Pancreatitis & Pancreatic Cancer
Tradjenta is in a drug class known as incretin mimetics and functions by inhibiting DPP-4, the enzyme that degrades hormones that stimulate insulin production in the pancreas, thereby regulating blood glucose levels. Unfortunately, there has been evidence that links incretin mimetics to an increased risk of pancreas inflammation, or pancreatitis. Pancreatitis is also a risk factor for pancreatic cancer, which is a serious and life-threating form of cancer. Common symptoms associated with pancreatic cancer include jaundice (yellowing of the skin or eyes), weight loss, abdominal pain and swelling, pale or light colored stools, dark colored urine, and others.

Thyroid Cancer
Medical studies have also found links between the use of Tradjenta and other diabetes medications and the development of thyroid cancer. The FDA has even issued a Drug Safety Communication for a similar diabetes drug known as Victoza® in response to lab studies that found increased rates of thyroid cancer in rats.

Speak with a California Lawyer to Discuss Your Case

Victims who have suffered adverse effects and damages after taking Tradjenta can find the earnest support and legal assistance they need at The Senators Firm. Proud advocates for victims' rights, our legal team is here to review your case and inform you about your eligibility to pursue a civil lawsuit. As pharmaceutical corporations are required to ensure that their products are safe, they can be held fully liable in the event that their products cause consumers and patients preventable harm. Take the preemptive steps needed to learn more about your rights and ability to secure the compensation you rightfully deserve. Contact a California lawyer from The Senators Firm to discuss your potential claim.

Attorney Web Design The information on this website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship.

View Full Disclaimer

The Senators (Ret.) Firm, LLP - California Lawyer
Located at:
19100 Von Karman Ave, Suite 850
Irvine CA 92612
Phone: (800) 773-0849
Website:
© 2018 All Rights Reserved.
Friend us on Facebook Follow us on Twitter View our Google+ Page
800.773.0849